Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease
Article 2016 en
Authors
SH
Satoru Hagiwara
NN
Naoshi Nishida
TW
Tomohiro Watanabe
Abstract
1 min read
A favorable SVR was achieved by SOF/LDV therapy even in elderly patients, those with liver cirrhosis, or those having undergone radical treatment of liver cancer. Furthermore, a high tolerance was demonstrated, but adverse reactions associated with the heart may appear in patients with heart disease as an underlying disease; strict management during treatment is necessary.
Kayo Seo, Soo Ki Kim, Soo Ryang Kim, Aya Ohtani, Mana Kobayashi, Airi Kato, Eri Morimoto, Yuka Saijo, Ke Ih Kim, Susumu Imoto, Chi Wan Kim, Yoshihiko Yano, Masatoshi Kudo, Yoshitake Hayashi
Discussion(0)
No comments yet. Be the first to comment.